A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Hoffmann-La Roche
Related studies linked through entity extraction aliases.
REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy
- Status
- COMPLETED
- Phase
- PHASE4
PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE4
Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).
- Status
- COMPLETED
- Phase
- PHASE4
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.
- Status
- COMPLETED
- Phase
- PHASE4
Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin
- Status
- COMPLETED
- Phase
- PHASE4
Study of Enfuvirtide in HIV-Positive Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
- Status
- COMPLETED
- Phase
- PHASE3
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).
- Status
- COMPLETED
- Phase
- PHASE4
ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE3